Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.
about
A review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingComparative oncology: what dogs and other species can teach us about humans with cancerTreatment of glioblastoma in elderly patients.An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients.Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations.Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapyGATA4 and DcR1 methylation in glioblastomas.Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model.The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy.Neoplasia: An Anniversary of Progress.Loss of heterozygosity and uniparental disomy of chromosome region 10q23.3-26.3 in glioblastoma.Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas.The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
P2860
Q28389391-D4472F98-4360-4E07-A126-632715021401Q28395095-8EFFD867-8215-4CEB-B6A7-C1B3AFB00584Q28607304-0D9371D0-96E8-463D-9130-C43AD9A1BDC6Q30838145-1896B5F4-8DA5-41CF-9F52-0443E7F62DA3Q34149065-2291BB9B-B46A-4DB0-ADAC-EACEDFC805A5Q34625644-95B2BAAF-5515-4B82-9B0D-B096278999A1Q35356484-E1EEE11F-B218-47E9-9E25-96B4D6D5024BQ36688785-68BA69CA-7C04-47F6-9D6E-356098C2D579Q36690240-B1A9CD22-72D7-4C4C-A794-714D41115653Q36982114-1F906000-02FB-4A0B-9DC4-BD31C713ACADQ41009177-A31B6F67-A9E3-469F-BD1F-492EBDB8CFFEQ42289519-281E7698-2A25-4D69-8653-2E9503C93014Q46932476-747E14E2-C239-4AB2-85F2-5FF3D019606AQ48091842-FF1FEF90-F8D8-457E-833B-8B2E2C61D659Q49645086-745FABB8-FEFA-455C-9485-9F526DE6CC85Q56333957-33FCF909-C91A-40C3-9FF0-567BC44794B5
P2860
Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Patients with high-grade gliom ...... t from temozolomide treatment.
@ast
Patients with high-grade gliom ...... t from temozolomide treatment.
@en
Patients with high-grade gliom ...... t from temozolomide treatment.
@nl
type
label
Patients with high-grade gliom ...... t from temozolomide treatment.
@ast
Patients with high-grade gliom ...... t from temozolomide treatment.
@en
Patients with high-grade gliom ...... t from temozolomide treatment.
@nl
prefLabel
Patients with high-grade gliom ...... t from temozolomide treatment.
@ast
Patients with high-grade gliom ...... t from temozolomide treatment.
@en
Patients with high-grade gliom ...... t from temozolomide treatment.
@nl
P2093
P2860
P50
P356
P1433
P1476
Patients with high-grade gliom ...... t from temozolomide treatment.
@en
P2093
Christian Hartmann
Eckart Meese
Florian Stockhammer
Klaus D Zang
Martin Strowitzki
Ralf Ketter
Silke Wemmert
Steffi Urbschat
Wolf-Ingo Steudel
Wolfgang Feiden
P2860
P304
P356
10.1593/NEO.05307
P577
2005-10-01T00:00:00Z